Cargando…
Targeting DNA topoisomerase IIα (TOP2A) in the hypoxic tumour microenvironment using unidirectional hypoxia‐activated prodrugs (uHAPs)
The hypoxic tumour microenvironment (hTME), arising from inadequate and chaotic vascularity, can present a major obstacle for the treatment of solid tumours. Hypoxic tumour cells compromise responses to treatment since they can generate resistance to radiotherapy, chemotherapy and immunotherapy. The...
Autores principales: | Smith, Paul J., McKeown, Stephanie R., Patterson, Laurence H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084299/ https://www.ncbi.nlm.nih.gov/pubmed/35499745 http://dx.doi.org/10.1002/iub.2619 |
Ejemplares similares
-
Targeting hypoxic microenvironment of pancreatic xenografts with the hypoxia-activated prodrug TH-302
por: Lohse, Ines, et al.
Publicado: (2016) -
Targeting the hypoxic fraction of tumours using hypoxia-activated prodrugs
por: Phillips, Roger M.
Publicado: (2016) -
Topoisomerase gets around
por: Dove, Alan W.
Publicado: (2002) -
AQ4N: a new approach to hypoxia-activated cancer chemotherapy
por: Patterson, L H, et al.
Publicado: (2000) -
Hypoxia-activated prodrug TH-302 decreased survival rate of canine lymphoma cells under hypoxic condition
por: Yamazaki, Hiroki, et al.
Publicado: (2017)